Fidelity Investments’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.6M Sell
2,909,964
-322,355
-10% -$7.59M ﹤0.01% 1268
2025
Q1
$77.6M Buy
3,232,319
+179,193
+6% +$4.3M 0.01% 1190
2024
Q4
$129M Buy
3,053,126
+267,842
+10% +$11.3M 0.01% 1009
2024
Q3
$123M Sell
2,785,284
-16,654
-0.6% -$736K 0.01% 1013
2024
Q2
$101M Sell
2,801,938
-321,330
-10% -$11.6M 0.01% 1035
2024
Q1
$135M Buy
3,123,268
+348,896
+13% +$15M 0.01% 940
2023
Q4
$42.7M Sell
2,774,372
-2,670,994
-49% -$41.1M ﹤0.01% 1350
2023
Q3
$74.7M Sell
5,445,366
-1,090,194
-17% -$14.9M 0.01% 1094
2023
Q2
$105M Buy
6,535,560
+739,301
+13% +$11.9M 0.01% 973
2023
Q1
$45M Buy
5,796,259
+1,647,613
+40% +$12.8M ﹤0.01% 1302
2022
Q4
$80.3M Buy
4,148,646
+92,305
+2% +$1.79M 0.01% 1056
2022
Q3
$86.4M Buy
4,056,341
+40,990
+1% +$873K 0.01% 1010
2022
Q2
$54.6M Buy
4,015,351
+3,321
+0.1% +$45.2K 0.01% 1221
2022
Q1
$94.2M Buy
4,012,030
+866,828
+28% +$20.4M 0.01% 1089
2021
Q4
$84M Buy
3,145,202
+5,800
+0.2% +$155K 0.01% 1190
2021
Q3
$52.6M Buy
3,139,402
+16,890
+0.5% +$283K ﹤0.01% 1386
2021
Q2
$38.5M Buy
+3,122,512
New +$38.5M ﹤0.01% 1556